According to reports, many are turning to weight-loss medicines as “a quick fix” to shed a few pounds and get “beach-body ready” for summer, which worries NHS England’s medical director.
According to Professor Stephen Powis, the medications should only be taken under medical supervision because of the potentially harmful adverse effects.
When tests revealed that Wegovy users might lose more than 10% of their body weight, interest in the medication for treating obesity increased.
Nowadays, drug therapies are considered a crucial weapon in the fight against obesity.
People at the highest end of the obesity spectrum may be offered Wegovy, a weight-loss injection, through specialized weight management clinics on the NHS in England. Semaglutide, a medication that decreases appetite and helps patients feel full, is included in it.
Mounjaro, a different anti-obesity medication, may shortly be suggested for use by the NHS.
Ozempic, a medication for type 2 diabetes, also contains semaglutide. There is a shortage of the drug for diabetics, despite the fact that it has not been approved to help obese people lose weight.
For between £100 and £200, many internet pharmacies sell semaglutide injections; however, they don’t verify the buyer’s weight or general health.
